Physician profile
Devon Thomas
NPI 1245859305
$2,681.37
in general payments reported to CMS, 2019-2025
14 companies · $1,963 in 2025
The $1,963 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $260 · 2024: $458 · 2025: $1,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,709 · Travel and Lodging: $904 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,708.99 |
| Travel and Lodging | $904.38 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,837.47 | 2023-2025 | Titan |
| Urogen Pharma, INC. | $149.17 | 2024-2025 | |
| Astellas Pharma US INC | $130.54 | 2023-2025 | Xtandi |
| Medtronic, INC. | $123.74 | 2025 | Interstim |
| Janssen Biotech, INC. | $122.79 | 2025 | Erleada |
| Boston Scientific Corporation | $79.94 | 2025 | Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $61.79 | 2025 | |
| Becton, Dickinson and Company | $49.61 | 2025 | Purewick Female External Catheter |
| Dendreon Pharmaceuticals LLC | $32.61 | 2025 | Provenge |
| Pfizer INC. | $25.42 | 2025 | |
| Angiodynamics, INC. | $19.85 | 2025 | Nanoknife |
| Bioprotect Medical, INC. | $17.58 | 2025 | Bioprotect Balloon Implant System |
| Ferring Pharmaceuticals INC. | $16.55 | 2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $14.31 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devon Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.